Capital Markets Trading Uk LLP Gilead Sciences, Inc. Transaction History

Capital Markets Trading Uk LLP

$6.78 Billion
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $319,602 - $400,496	-5,518 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$64.88 - $73.64 $1.08 Million - $1.22 Million	-16,620 Reduced 75.07%	5,518 $401,000
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $3.73 Million - $4.02 Million	-55,036 Reduced 71.31%	22,138 $1.57 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $1.74 Million - $1.9 Million	27,352 Added 54.9%	77,174 $5.31 Million
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $196,440 - $224,138	3,274 Added 7.03%	49,822 $3.22 Million

Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $314,804 - $358,704	5,557 Added 13.56%	46,548 $2.71 Million
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $1.98 Million - $2.49 Million	31,894 Added 350.6%	40,991 $2.48 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $658,076 - $764,148	9,097 New	9,097 $700,000
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $5.29 Million - $6.77 Million	-84,393 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $3.01 Million - $3.31 Million	48,821 Added 137.25%	84,393 $5.48 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $839,321 - $926,463	13,427 Added 60.63%	35,572 $2.26 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $357,794 - $401,224	5,783 Added 35.34%	22,145 $1.5 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $4.63 Million - $5.19 Million	-74,103 Reduced 81.91%	16,362 $1.06 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $871,776 - $1.14 Million	14,400 Added 18.93%	90,465 $5.66 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $2.68 Million - $2.97 Million	-37,641 Reduced 33.1%	76,065 $5.87 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $4.27 Million - $4.98 Million	65,763 Added 137.17%	113,706 $8.06 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $3.14 Million - $3.83 Million	43,114 Added 892.81%	47,943 $3.61 Million
Q4 2017 Feb 15, 2018	BUY	$71.15 - $83.52 $343,583 - $403,318	4,829	4,829 $346,000

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

Black Rock Inc. New York, NY

123M
Shares

$8.38 Billion
0.21% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$7.85 Billion
0.17% of portfolio
Capital World Investors Los Angeles, CA

84.5M
Shares

$5.78 Billion
1.06% of portfolio
Capital Research Global Investors Los Angeles, CA

61.2M
Shares

$4.19 Billion
1.05% of portfolio
State Street Corp Boston, MA

57.7M
Shares

$3.95 Billion
0.19% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $85.7B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Markets Trading Uk LLP, based on Form 13F filings with the SEC.

News

Stay updated on Capital Markets Trading Uk LLP with notifications on news.

Account